1. Alternating R‐CHOP and R‐cytarabine is a safe and effective regimen for transplant‐ineligible patients with a newly diagnosed mantle cell lymphoma. Issue 1 (30th October 2017) Authors: Klener, Pavel; Fronkova, Eva; Belada, David; Forsterova, Kristina; Pytlik, Robert; Kalinova, Marketa; Simkovic, Martin; Salek, David; Mocikova, Heidi; Prochazka, Vit; Blahovcova, Petra; Janikova, Andrea; Markova, Jana; Obr, Ales; Berkova, Adela; Kubinyi, Jozef; Vaskova, Martina; Mejstrikova, Este... Journal: Hematological oncology Issue: Volume 36:Issue 1(2018) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients. Issue 6 (12th May 2019) Authors: Mareckova, Andrea; Malcikova, Jitka; Tom, Nikola; Pal, Karol; Radova, Lenka; Salek, David; Janikova, Andrea; Moulis, Mojmir; Smardova, Jana; Kren, Leos; Mayer, Jiri; Trbusek, Martin Journal: Leukemia & lymphoma Issue: Volume 60:Issue 6(2019) Page Start: 1420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study. Issue 4 (April 2015) Authors: Cheah, Chan Yoon; Belada, David; Fanale, Michelle A; Janikova, Andrea; Czucman, Myron S; Flinn, Ian W; Kapp, Amy V; Ashkenazi, Avi; Kelley, Sean; Bray, Gordon L; Holden, Scott; Seymour, John F Journal: Lancet Issue: Volume 2:Issue 4(2015) Page Start: e166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database. Issue 5 (3rd May 2016) Authors: Janikova, Andrea; Bortlicek, Zbynek; Campr, Vit; Kopalova, Natasa; Benesova, Katerina; Hamouzova, Jitka; Belada, David; Prochazka, Vit; Pytlik, Robert; Vokurka, Samuel; Pirnos, Jan; Duras, Juraj; Mocikova, Heidi; Mayer, Jiri; Trneny, Marek Journal: Leukemia & lymphoma Issue: Volume 57:Issue 5(2016:May) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Maintenance rituximab in newly diagnosed mantle cell lymphoma patients: a real world analysis from the Czech lymphoma study group registry†. Issue 3 (23rd February 2019) Authors: Obr, Aleš; Prochazka, Vit; Papajik, Tomas; Klener, Pavel; Janikova, Andrea; Salek, David; Belada, David; Pytlík, Robert; Sykorova, Alice; Mocikova, Heidi; Simkovic, Martin; Campr, Vit; Dlouha, Jitka; Furst, Tomas; Trněný, Marek Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B‐cell lymphoma in the real world. (11th May 2022) Authors: Vodicka, Prokop; Benesova, Katerina; Janikova, Andrea; Prochazka, Vit; Belada, David; Mocikova, Heidi; Steinerova, Katerina; Duras, Juraj; Karban, Josef; Hanackova, Veronika; Sykorova, Alice; Obr, Ales; Trneny, Marek Journal: European journal of haematology Issue: Volume 109:Number 2(2022) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Potential loss of prognostic significance of minimal residual disease assessment after R‐CHOP‐based induction in elderly patients with mantle cell lymphoma in the era of rituximab maintenance. Issue 5 (13th September 2018) Authors: Klener, Pavel; Fronkova, Eva; Kalinova, Marketa; Belada, David; Forsterova, Kristina; Pytlik, Robert; Blahovcova, Petra; Simkovic, Martin; Salek, David; Mocikova, Heidi; Prochazka, Vit; Janikova, Andrea; Vaskova, Martina; Mejstrikova, Ester; Kodet, Roman; Trka, Jan; Trneny, Marek Journal: Hematological oncology Issue: Volume 36:Issue 5(2018) Page Start: 773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Radiotherapy in early stage follicular lymphoma: is it really the gold standard?. Issue 10 (3rd October 2015) Authors: Janikova, Andrea Journal: Leukemia & lymphoma Issue: Volume 56:Issue 10(2015:Oct.) Page Start: 2999 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?. Issue 8 (3rd August 2015) Authors: Janikova, Andrea; Bortlicek, Zbynek; Campr, Vit; Kopalova, Natasa; Benesova, Katerina; Belada, David; Prochazka, Vit; Pytlik, Robert; Vokurka, Samuel; Pirnos, Jan; Duras, Juraj; Mocikova, Heidi; Mayer, Jiri; Trneny, Marek Journal: Leukemia & lymphoma Issue: Volume 56:Issue 8(2015:Aug.) Page Start: 2350 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Resminostat in patients with relapsed or refractory Hodgkin lymphoma: results of the phase II SAPHIRE study. Issue 3 (23rd February 2019) Authors: Walewski, Jan; Paszkiewicz-Kozik, Ewa; Borsaru, Gabriela; Hellmann, Andrzej; Janikova, Andrea; Warszewska, Agnieszka; Mais, Anna; Ammendola, Astrid; Herz, Thomas; Krauss, Babett; Henning, Stefan W. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 3(2019) Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗